Valeant takes over Probiotica in Brazil
The transaction is expected to be immediately accretive. Probiotica currently markets a full line of OTC sports nutrition products and other food supplements, with a 30% share of
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.